Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.
Betina Ip and brain illustration

Dr Betina Ip has been awarded a Dorothy Hodgkin Fellowship by the Royal Society, for her research ' Investigating the neurochemistry of human binocular perception and plasticity using advanced in vivo high field MR spectroscopy.’ The fellowship offers a recognised first step into an independent research career for outstanding post-doctoral scientists who need a flexible working pattern due to parenting or caring responsibilities.

Dr Ip’s award will support her research on neuroplasticity in the healthy and developmentally abnormal binocular visual system. Her research can inform treatments for ‘lazy eye’, the most common visual pathology in children that is associated with loss of normal binocular vision.

A better understanding on what promotes and limits plasticity in the brain is critical for treating neurodevelopmental disorders as well as for recovery from brain injury and disease. Animal studies have shown that the inhibitory neurotransmitter GABA is an essential part of experience-dependent plasticity in the developing brain. Magnetic Resonance Spectroscopy, a non-invasive brain imaging technique, is the only method that can measure GABA levels in the living human brain. By being sensitive to the minute shifts in the magnetic resonance signal of protons generated by the chemical structure of metabolites, MRS detects and quantifies their concentrations. 

Using this ‘chemical’ camera, a major goal of Betina’s research will be to take pictures of GABA concentrations in the visual cortex of participants who learn to see better using two eyes. Through this work, she aims to understand how the adult brain reorganises due to sensory experience. 

Read more on the Royal Society website.

Similar stories

Insights into the molecular pathways of progressive multiple sclerosis

Text by Ian Fyfe for 'Nature Reviews Neurology'

Discovery of gene involved in chronic pain creates new treatment target

Our researchers have discovered a gene that regulates pain sensitisation by amplifying pain signals within the spinal cord. This is helping them to understand an important mechanism underlying chronic pain in humans, and provides a new treatment target.

Lymph nodes reveal more about mechanisms of autoimmunity

Two recent papers show that studying lymph nodes reveals details of the mechanisms of autoimmunity.

Multiple heart-related conditions linked to triple dementia risk, regardless of genetics

Having multiple conditions that affect the heart is linked to a greater risk of dementia than having high genetic risk, according to a large-scale new study.

NDCN research presented at Myasthenia Gravis conference

The 14th Quinquennial Myasthenia Gravis Federation of America International Conference was recently held in Miami with 450 delegates attending in person, including over 100 from industry.

Magnetic signatures of the brain characterised in UK Biobank imaging study

A study published this week in Nature Neuroscience demonstrates how studying the magnetic properties of tissue may provide a unique window into brain health and disease.